MARATTO

article · Diagnostics

A Comprehensive Clinical Assessment of the LumiraDx International Normalized Ratio (INR) Assay for Point-of-Care Monitoring in Anticoagulation Therapy

20241 citationOpen accessUniversity of the Witwatersrand

Abstract

The LumiraDx INR Test showed a good performance compared to laboratory-based testing and provided opportunity for rapid and patient-centric care. Owing to an increasing positive bias for INR > 3.5, confirmation with laboratory INR measurements may be required.

Research topics

  • Clinical Laboratory Practices and Quality Control
  • Reliability and Agreement in Measurement
  • Hemodynamic Monitoring and Therapy

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3390/diagnostics14232683

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.